Kbc Group Nv Ironwood Pharmaceuticals Inc Transaction History

Kbc Group Nv

$33.1 Billion
Q3 2024

A detailed history of Kbc Group Nv transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Kbc Group Nv holds 8,593 shares of IRWD stock, worth $31,536. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,593

Previous 5,395 59.28%

Holding current value

$31,536

Previous $35,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$3.93 - $7.04 $12,568 - $22,513	3,198 Added 59.28%	8,593 $35,000
Q2 2024 Jul 17, 2024	BUY	$5.58 - $8.61 $3,498 - $5,398	627 Added 13.15%	5,395 $35,000
Q4 2023 Feb 13, 2024	SELL	$8.79 - $11.51 $55,174 - $72,248	-6,277 Reduced 56.83%	4,768 $55,000
Q3 2023 Feb 15, 2024	SELL	$8.25 - $11.35 $51,785 - $71,243	-6,277 Reduced 56.83%	4,768 $46,000
Q2 2023 Feb 15, 2024	SELL	$10.1 - $11.6 $14,382 - $16,518	-1,424 Reduced 11.42%	11,045 $118,000
Q2 2023 Jul 28, 2023	BUY	$10.1 - $11.6 $111,554 - $128,122	11,045 New	11,045 $118,000
Q1 2023 Feb 14, 2024	SELL	$10.37 - $12.56 $14,766 - $17,885	-1,424 Reduced 11.42%	11,045 $116,000
Q4 2022 Feb 14, 2024	BUY	$9.9 - $12.43 $76,239 - $95,723	7,701 Added 161.51%	12,469 $154,000
Q3 2022 Feb 15, 2024	BUY	$10.14 - $12.38 $78,088 - $95,338	7,701 Added 161.51%	12,469 $129,000
Q3 2022 Nov 08, 2022	BUY	$10.14 - $12.38 $126,435 - $154,366	12,469 New	12,469 $129,000

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $562M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account